CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 100 of 593 entries

View as:

Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Phase: N/A Priority: Normal

NCT ID: NCT04742400 Org: User:

Start: 04/15/21 End: 12/31/25 Due: 12/31/26

Brain Changes Associated With Learning a Motor Task

Phase: N/A Priority: Normal

NCT ID: NCT00076466 Org: User:

Start: 01/22/04 End: 01/14/09 Due: 01/14/10

Stimulating Deep Brain Regions With a Magnetic Stimulator

Phase: N/A Priority: Normal

NCT ID: NCT00063245 Org: User:

Start: 06/30/03 End: 04/30/05 Due: 04/30/06

Effect of Transcranial Magnetic Stimulation on Free Will

Phase: N/A Priority: Normal

NCT ID: NCT00029653 Org: User:

Start: 01/31/02 End: 06/30/02 Due: 06/30/03

Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance

Phase: N/A Priority: Normal

NCT ID: NCT00060866 Org: User:

Start: 05/31/03 End: 03/31/05 Due: 03/31/06

Structural and Functional Neuroimaging Studies of Combat Veterans

Phase: N/A Priority: Normal

NCT ID: NCT01296126 Org: User:

Start: 01/26/11 End: 02/03/14 Due: 02/03/15

Motor Changes Associated With Recovery From Stroke After Therapy

Phase: N/A Priority: Normal

NCT ID: NCT00001553 Org: User:

Start: 05/31/96 End: 03/31/01 Due: 03/31/02

Brain Activity in Visual-Motor Behavior

Phase: N/A Priority: Normal

NCT ID: NCT00077038 Org: User:

Start: 02/06/04 End: 03/31/07 Due: 03/31/08

Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus

Phase: N/A Priority: Normal

NCT ID: NCT00004297 Org: User:

Start: 11/30/95 End: 02/28/99 Due: 02/28/00

Language and Emotional Function in Patients With Temporal Lobe Epilepsy

Phase: N/A Priority: Normal

NCT ID: NCT00081432 Org: User:

Start: 04/09/04 End: 04/27/10 Due: 04/27/11

Motor Training to Treat Hand Dystonia

Phase: N/A Priority: Normal

NCT ID: NCT00021853 Org: User:

Start: 08/31/01 End: 08/31/02 Due: 08/31/03

Riluzole to Treat Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT00013624 Org: User:

Start: 03/31/01 End: 03/31/05 Due: 03/31/06

Evaluation of Primary Chronic Autonomic Failure

Phase: N/A Priority: Normal

NCT ID: NCT00059033 Org: User:

Start: 04/10/03 End: 10/30/18 Due: 10/30/19

Spinal Reflexes in Motor Skill Learning

Phase: N/A Priority: Normal

NCT ID: NCT00076583 Org: User:

Start: 01/31/04 End: 11/30/05 Due: 11/30/06

Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury

Phase: N/A Priority: Normal

NCT ID: NCT00004759 Org: User:

Start: 12/31/91 End: - Due: -

Effect of Surface Electrical Stimulation on Movement of the Larynx

Phase: N/A Priority: Normal

NCT ID: NCT00104000 Org: User:

Start: 02/28/05 End: 01/31/06 Due: 01/31/07

SMN Copy Number Distribution in Mali, West Africa

Phase: N/A Priority: Normal

NCT ID: NCT01059240 Org: User:

Start: 01/21/10 End: 05/18/17 Due: 05/18/18

Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis

Phase: N/A Priority: Normal

NCT ID: NCT00334516 Org: User:

Start: 06/06/06 End: 08/03/15 Due: 08/03/16

Timing of Levodopa Treatment in Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT00004733 Org: User:

Start: 01/31/98 End: 02/29/04 Due: 02/28/05

Electrical Muscle Stimulation to Aid Swallowing in Dysphagia

Phase: N/A Priority: Normal

NCT ID: NCT00001936 Org: User:

Start: 09/28/99 End: - Due: -

Treatment of Huntington's Chorea With Amantadine

Phase: N/A Priority: Normal

NCT ID: NCT00001930 Org: User:

Start: 04/30/99 End: 02/28/01 Due: 02/28/02

Monitoring Patients With Uncontrolled Epilepsy

Phase: N/A Priority: Normal

NCT ID: NCT00001149 Org: User:

Start: 11/30/75 End: 01/31/02 Due: 01/31/03

Characteristics of Parkinson s Disease Associated With the LRRK-2 Gene Mutation

Phase: N/A Priority: Normal

NCT ID: NCT00467090 Org: User:

Start: 04/23/07 End: 02/03/14 Due: 02/03/15

Alternative Dosing and Regimen of Replagal to Treat Fabry Disease

Phase: N/A Priority: Normal

NCT ID: NCT00075244 Org: User:

Start: 01/31/04 End: 11/30/05 Due: 11/30/06

Magnetic Resonance Imaging of the Brain in Emotional Processing

Phase: N/A Priority: Normal

NCT ID: NCT00061204 Org: User:

Start: 05/31/03 End: 04/30/06 Due: 04/30/07

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis	NCT04742400	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2021-04-15	2025-12-31	2026-12-31	-	-	2025-07-14
Brain Changes Associated With Learning a Motor Task	NCT00076466	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2004-01-22	2009-01-14	2010-01-14	-	-	2025-07-14
Stimulating Deep Brain Regions With a Magnetic Stimulator	NCT00063245	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2003-06-30	2005-04-30	2006-04-30	-	-	2025-07-14
Effect of Transcranial Magnetic Stimulation on Free Will	NCT00029653	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2002-01-31	2002-06-30	2003-06-30	-	-	2025-07-14
Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance	NCT00060866	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2003-05-31	2005-03-31	2006-03-31	-	-	2025-07-14
Structural and Functional Neuroimaging Studies of Combat Veterans	NCT01296126	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2011-01-26	2014-02-03	2015-02-03	-	-	2025-07-14
Motor Changes Associated With Recovery From Stroke After Therapy	NCT00001553	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	1996-05-31	2001-03-31	2002-03-31	-	-	2025-07-14
Brain Activity in Visual-Motor Behavior	NCT00077038	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2004-02-06	2007-03-31	2008-03-31	-	-	2025-07-14
Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus	NCT00004297	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	1995-11-30	1999-02-28	2000-02-28	-	-	2025-07-14
Language and Emotional Function in Patients With Temporal Lobe Epilepsy	NCT00081432	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2004-04-09	2010-04-27	2011-04-27	-	-	2025-07-14
Motor Training to Treat Hand Dystonia	NCT00021853	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2001-08-31	2002-08-31	2003-08-31	-	-	2025-07-14
Riluzole to Treat Parkinson's Disease	NCT00013624	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2001-03-31	2005-03-31	2006-03-31	-	-	2025-07-14
Evaluation of Primary Chronic Autonomic Failure	NCT00059033	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2003-04-10	2018-10-30	2019-10-30	-	-	2025-07-14
Spinal Reflexes in Motor Skill Learning	NCT00076583	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2004-01-31	2005-11-30	2006-11-30	-	-	2025-07-14
Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury	NCT00004759	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	1991-12-31	-	-	-	-	2025-07-14
Effect of Surface Electrical Stimulation on Movement of the Larynx	NCT00104000	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2005-02-28	2006-01-31	2007-01-31	-	-	2025-07-14
SMN Copy Number Distribution in Mali, West Africa	NCT01059240	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2010-01-21	2017-05-18	2018-05-18	-	-	2025-07-14
Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis	NCT00334516	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2006-06-06	2015-08-03	2016-08-03	-	-	2025-07-14
Timing of Levodopa Treatment in Parkinson's Disease	NCT00004733	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	1998-01-31	2004-02-29	2005-02-28	-	-	2025-07-14
Electrical Muscle Stimulation to Aid Swallowing in Dysphagia	NCT00001936	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	1999-09-28	-	-	-	-	2025-07-14
Treatment of Huntington's Chorea With Amantadine	NCT00001930	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	1999-04-30	2001-02-28	2002-02-28	-	-	2025-07-14
Monitoring Patients With Uncontrolled Epilepsy	NCT00001149	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	1975-11-30	2002-01-31	2003-01-31	-	-	2025-07-14
Characteristics of Parkinson s Disease Associated With the LRRK-2 Gene Mutation	NCT00467090	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2007-04-23	2014-02-03	2015-02-03	-	-	2025-07-14
Alternative Dosing and Regimen of Replagal to Treat Fabry Disease	NCT00075244	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2004-01-31	2005-11-30	2006-11-30	-	-	2025-07-14
Magnetic Resonance Imaging of the Brain in Emotional Processing	NCT00061204	National Institute of Neurological Disorders and Stroke (NINDS)	user2@example.com	None	2003-05-31	2006-04-30	2007-04-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance